SAN MATEO, California, July 21 /PRNewswire/ --

- Trend Micro Integrates Smart Protection Network technology Into Bizanga's Intelligent Message Platform

Bizanga, provider of the world's leading email and message management platform, today announced an extended partnership with Trend Micro Incorporated, a global leader in Internet content security. Through this partnership, Bizanga has integrated elements of Trend Micro's Smart Protection Network into Bizanga Intelligent Message Processor (IMP) platform while maintaining impressive performance results. The solution is already operational in several major carriers and is available immediately.

ELMSHORN, Germany, July 21 /PRNewswire/ --

- The XPC Barebone SX48P2 Deluxe Starts Up With an Extensive Equipment Package - the Peak of Mini-PC Performance With 1600 MHz FSB

Shuttle Inc., market leader in the mini-PC segment and manufacturer of Multi-Form-Factor solutions, today unveils a new XPC Barebone from the P2 model series building on Intel's X48 Express chipset. Specially designed for high performance systems, the XPC Barebone SX48P2 Deluxe is ideally suited for Core 2 Duo and Core 2 Quad processors with up to four cores.

The XPC Barebone SX48P2 Deluxe is the first mini PC barebone ready to be equipped with DDR3 memory modules. A maximum capacity of eight Gigabytes on four sockets can be installed into this model.

KING OF PRUSSIA, Pennsylvania, July 21 /PRNewswire/ --

GSI Commerce Inc. (Nasdaq: GSIC), a leading provider of e-commerce and multichannel solutions, announced today that iRobot (Nasdaq: IRBT) is utilizing GSI's e-commerce platform to power its direct-to-consumer business in Europe through online stores in the U.K. (www.iroboteurope.co.uk) and Germany (www.iroboteurope.de).

LONDON, July 21 /PRNewswire/ -- NHS Choices (http://www.nhs.uk), the digital 'front door' to the NHS, launches a new Live well section aimed to help African and African Caribbean people, and mixed-race people of African or African Caribbean descent, protect their health. Some conditions, such as diabetes, high blood pressure and prostate cancer, are more prevalent in people from these communities in the UK.

LONDON, July 21 /PRNewswire/ -- The CUPID (Cannabinoid Use in Progressive Inflammatory brain Disease) study at the Peninsula Medical School has reached an important milestone with the news that the full cohort of 493 patients with multiple sclerosis (MS) has been recruited to the programme.

CUPID is a clinical trial part-funded by the MS Society, which will evaluate whether tetrahydrocannabinol (THC) - the main active ingredient in the cannabis plant and one of many compounds found in the organism - is able to slow the progression of MS.

It is an important study for people with MS, because current treatments either target the immune system in the early stages of MS, or ease specific symptoms such as muscle spasms or bladder problems.